New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 16, 2014
04:55 EDTVCYT, VCYT, VCYT, VCYT, VCYT, VCYT, AZN, AZN, AZN, AZN, AZN, AZN, INSM, INSM, INSM, INSM, INSM, INSM, ITMN, ITMN, ITMN, ITMN, ITMN, ITMN, XNCR, XNCR, XNCR, XNCR, XNCR, XNCRAmerican Thoracic Society to hold a conference
ATS 2014 San Diego to be held on May 16-21.
News For VCYT;AZN;INSM;ITMN;XNCR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 18, 2014
08:03 EDTXNCRXencor and Novo Nordisk partner for novel drug development
Subscribe for More Information
December 15, 2014
07:33 EDTAZNAdvaxis announces FDA acceptance of INDA to commence clinical trials of ADXS-HPV
Subscribe for More Information
07:07 EDTINSMInsmed provides end of year regulatory and clinical update
Subscribe for More Information
December 11, 2014
16:03 EDTAZNAmgen, AstraZeneca to present results from Phase 3 plaque psoriasis study
Subscribe for More Information
09:17 EDTINSMInsmed management to meet with Leerink
Subscribe for More Information
07:28 EDTAZNCBI to hold a summit
2nd Specialty Data Optimization Summit is being held in Philadelphia on December 11.
December 9, 2014
09:10 EDTAZNARIAD takeover rumors rekindled, Independent says
Subscribe for More Information
08:02 EDTAZNMoventig approved in EU for opioid-induced constipation
Nektar (NKTR) reported partner AstraZeneca (AZN) announced that MOVENTIG has been granted Marketing Authorisation by the European Commission for the treatment of opioid-induced constipation in adult patients who have had an inadequate response to laxative. MOVENTIG is the first once-daily oral peripherally-acting mu-opioid receptor antagonist to be approved in the European Union.
07:44 EDTAZNAmerican Association for Cancer Research to hold a symposium
Subscribe for More Information
December 8, 2014
07:26 EDTVCYTLeerink to hold a tour
Subscribe for More Information
07:05 EDTAZNInnocoll appoints Tony Zook as CEO
Innocoll AG (INNL) announced that Tony Zook, formerly executive vice president, Global Commercial Operations, at AstraZeneca (AZN), has been appointed CEO effectively immediately. Michael Myers, will continue with the company as head of Portfolio Operations.
December 7, 2014
14:59 EDTXNCRMorphoSys and Xencor publish final results from Phase 1/2a trial of MOR208
MorphoSys and Xencor (XNCR) announced the publication of final results of a Phase 1/2a trial evaluating MOR208 in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic leukemia. MOR208 is a potent anti-CD19 antibody with a proprietary modification to the Fc portion that is being developed to treat B-cell malignancies. MOR208 was in-licensed by MorphoSys from Xencor in 2010.The results demonstrate that the drug was well tolerated and achieved durable responses in a high risk and poor prognosis patient population with significant progression-free survival achieved.
December 6, 2014
09:38 EDTXNCRXencor to hold a meeting
Subscribe for More Information
December 5, 2014
09:49 EDTAZNUBS European pharmaceuticals analysts holds analyst/industry conference call
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use